施乐辉 SNN 深沪

已收盘 06-12 16:00:00 美东时间

30.57

-0.100

-0.33%

华盛通

立即下载

最高30.74
今开30.70
成交量 69.81万股
最低 30.36
昨收 30.67
总市值 129.89亿
52周最高 38.038
市盈率 ^静 21.30
换手率 0.16%
52周最低 28.048
委比 -0.50%
总股本 4.25亿
历史最高 47.416
量比 0.58
振幅 1.24%
历史最低 8.426
每手 1
风险率 2.46%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

Smith+Nephew launch next generation LEAF™ Patient Monitoring System – an innovative pressure injury prevention platform delivering proven clinical impact

Smith+Nephew has launched the next generation of the LEAF Patient Monitoring System in the US, a data-driven platform designed to prevent hospital-acquired pressure injuries (HAPIs). The system uses wearable sensors to monitor patient mobility and provide real-time updates, improving workflow efficiency and adherence to turning protocols. With a redesigned user interface and seamless integration with hospital EMRs, LEAF helps reduce HAPIs by up t...

06-01 19:00
美股大行评级 | Arxis、Madison Air获多家大行首予买入评价！潜在涨幅441.87%！Caribou Biosciences获HC Wainwright & Co.升目标价至11美元，维持"买入"评级

今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从9美元升至11美元；康托·菲茨杰拉德：维持Artiva Biotherapeutics"超配"评级，目标价从10美元升至40美元

05-12 12:36
Smith & Nephew Sees FY2026 Sales $6.534B vs $6.557B Est

Smith & Nephew (NYSE:SNN) sees FY2026 sales of $6.534 billion vs $6.557 billion analyst estimate.

05-06 21:19
Smith & Nephew announces new $500 million share buyback program

Smith & Nephew announces new $500 million share buyback program Smith & Nephew launched a new USD 500 million share buyback to be completed within next 12 months. Program funded from free cash flow, existing cash balances. Buyback, ordinary dividends expected to return more than USD 835 million to s

05-06 18:43
Smith+Nephew To Showcase ALLEVYNCOMPLETE CARE Dressing And RENASYS EDGE tNPWT, To Simplify Wound Management And Ease Clinical Burden At EWMA 2026

Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, continues to drive progress in chronic wound management with an industry-leading portfolio set to showcase at the upcoming European WoundSmith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, continues to drive progress in chronic wound management with an i

05-06 01:05
Smith+Nephew drives progress in chronic wound care with ALLEVYN™COMPLETE CARE Dressing and RENASYS™ EDGE tNPWT set to launch at EWMA 2026

05-05 17:00
美股夜盘 | MaxLinear, Inc.涨34.89%，英特尔涨22.34%

MaxLinear, Inc.涨34.89%；英特尔涨22.34%；AppFolio Inc Class A涨8.70%

04-24 15:01
Smith+Nephew Reported Additional Data From Clinical Superiority Of Its CARTIHEAL AGILI-C Cartilage Repair Implant; Results Demonstrate Higher Overall Knee Injury And Osteoarthritis Outcome Scores

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces further compelling evidence from a multicenter, randomized controlled trial highlighting the clinical superiority of its CARTIHEAL

04-21 20:04
运动医学“国产尖兵”「天星医疗」通过港交所聆讯，毛利率超70%

2026年4月7日，来自北京的天星医疗通过港交所聆讯，拟在香港主板上市，联席保荐人为中信证券、建银国际。公司是一家立足中国的医疗器械公司，2024年收入3...

04-08 17:07
UK Stocks-Factors to watch on March 26

UK Stocks-Factors to watch on March 26 March 26 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening lower on Thursday, with futures FFIc1 down 0.22%. * ANGLO AMERICAN: Anglo American AAL.L and Chile's Codelco have received a green light from the South American nation's antitrust regulator for

03-26 13:29

派息除权日	每股总股息	派息日期
2026-03-27	0.47	2026-05-27
2025-10-03	0.28	2025-11-07
2025-03-28	0.45	2025-05-28
2024-10-04	0.27	2024-11-08
2024-04-01	0.45	2024-05-22
2023-10-05	0.28	2023-11-01
2023-03-30	0.45	2023-05-17
2022-09-29	0.28	2022-10-26
2022-03-31	0.45	2022-05-11
2021-09-30	0.28	2021-10-27
2021-04-05	0.45	2021-05-12
2020-10-01	0.28	2020-10-28
2020-04-02	0.45	2020-05-06
2019-10-03	0.28	2019-10-30
2019-04-04	0.43	2019-05-08
2018-10-04	0.27	2018-10-31
2018-04-05	0.44	2018-05-09
2017-10-05	0.24	2017-11-01
2017-03-29	0.37	2017-05-10
2016-10-05	0.24	2016-10-25
2016-04-20	0.37	2016-05-11
2015-10-07	0.23	2015-10-27
2015-04-15	0.36	2015-05-06
2014-10-22	0.21	2014-11-11
2014-04-17	0.83	2014-05-07
2013-10-09	0.51	2013-10-29
2013-04-17	0.79	2013-05-08
2012-10-10	0.49	2012-10-30
2012-04-18	0.52	2012-05-09
2011-10-12	0.32	2011-11-01
2011-04-29	0.47	2011-05-19
2010-10-13	0.29	2010-11-02
2010-04-21	0.43	2010-05-12
2009-10-14	0.27	2009-11-03
2009-04-15	0.41	2009-05-08
2008-10-15	0.25	2008-11-07
2008-04-16	0.37	2008-05-09
2007-10-17	0.23	2007-11-09
2007-04-18	0.34	2007-05-21
2006-10-18	0.20	2006-11-10
2006-04-19	0.31	2006-05-12
2005-10-19	0.18	2005-11-21
2005-04-20	0.30	2005-05-23
2004-10-20	0.17	2004-11-22
2004-04-21	0.27	2004-05-24
2003-08-13	0.29	2003-09-22
2003-04-17	0.49	2003-05-27
2002-10-16	0.28	2002-11-25
2002-04-17	0.42	2002-05-28
2001-11-07	0.25	2001-12-17
2001-04-18	0.40	2001-05-29
2000-11-08	0.24	2000-12-18
2000-08-07	5.56	2000-08-04
2000-05-04	0.60	2000-06-12

公司名称	施乐辉
行业分类	医疗设备
业务描述	Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

施乐辉 SNN 深 沪

30.57

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

施乐辉 SNN 深沪